Renaissance Capital logo

ESPR News

US IPO Recap: Market picks up the pace with ten IPOs, six price below the range

Deal flow picked up last week with ten IPOs pricing and raising almost $1.9 billion in proceeds. Though it was a strong week for pricings, six of the ten deals slashed their valuations in order to complete their offerings, and all five deals that priced on...read more

Esperion Therapeutics prices upsized IPO at $14, the midpoint of the range

Esperion Therapeutics, which is developing a treatment for elevated levels of low-density lipoprotein cholesterol, raised $70 million by offering 5.0 million shares at $14, within the range of $13 to $15. Esperion Therapeutics plans to list on the NASDAQ under...read more

US IPO Recap: Coty fades, Gigamon springs and 17 companies file or set terms

For the fifth consecutive week, at least one US IPO gained 30%, as Gigamon (GIMO) climbed nearly 50%. The week's most prominent IPO, Coty (COTY), faltered though, and the third scheduled deal, Aratana Therapeutics (PETX) was delayed. Nine more IPOs,...read more

Biotech Esperion Therapeutics sets terms for $63 million IPO

Esperion Therapeutics, a biotech focused on developing a treatment for patients with elevated levels of low-density lipoprotein cholesterol, announced terms for its IPO on Wednesday. The Plymouth, MI-based company plans to raise $63 million by offering 4.5...read more